shahkg

Surgeon and techie. Always looking for the best of everything.

[shahkg @KavinGShah]

https://t.co/fx6O0bEU4l

[Eric Topol @EricTopol]

On the epidemic of direct-to-consumer medical marketing in the United States https://t.co/OH8oXgmJve @JAMA_current (the only country in the world that lets this go on)

[shahkg @KavinGShah]

@drjohnm @VPplenarysesh @charlesornstein That’s a fantastic point; i know first-hand that Pharma is actively engaging firms on how to parter & influence ANYone that can right a script outside of traditional MDs.

[shahkg @KavinGShah]

@cricque Congrats!

[shahkg @KavinGShah]

Yo @PlenarySessShow what’s your thoughts on this? “Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials”

https://t.co/59qZ17Uy8N

[shahkg @KavinGShah]

@Giavanni_Ruffin Haha yessir!

[shahkg @KavinGShah]

@Giavanni_Ruffin and @corybell05 at TNDO gym been doing this for months…check yourself! https://t.co/xQf30UGM8L

[SportsCenter @SportsCenter]

315-lb deadlift to 42 inch box jump 👀

Saquon and Todd Gurley are getting after it. (via @travellegaines)

[Vincent Rajkumar @VincentRK]

The recommended expensive treatments are mostly marked as IIa. Level 1 is RCT data. Level IIa is “uniform consensus” among experts on the panel. This is also the threshold at which CMS agrees to pay for treatment. You can see why this is troubling. https://t.co/Oc6UxjEtuQ

[shahkg @KavinGShah]

Amazing!! Great job to the team. https://t.co/0Rg2kaTcjU

[Northwell Health @NorthwellHealth]

A team of Northwell surgeons have performed the first #robotic nipple-sparing mastectomy in the U.S. – a major breakthrough in breast #surgery. https://t.co/mRhD4wu5V1

[shahkg @KavinGShah]

@sp12015 @LIRR_Executive No it was restored at around 3am this morning. Still sucks though.

[shahkg @KavinGShah]

@LIRR WHEN WILL IT BE RESTORED????? A LOT OF PEOPLE HAVE TO WORK TOMORROW.

[shahkg @KavinGShah]

@LIRR you guys absolutely suck ass. Horrible communication on Friday and no service on the Port Wash line!?!? WTF!? Why am I paying for this shit?? #lifr #lirr

[Viren Kaul, MD @virenkaul]

Last minute journal club request by the program. Doing the ADRENAL trial. Will you kind twitter folks take this poll and tell me:

Will you prescribe steroids in septic shock now on?

PS: want to show the power of twitter so please RT, vote, and show some love!
#MedEd #pulmcc

[shahkg @KavinGShah]

Hahaha this sounds about right. https://t.co/LZv4Nkor1Z

[shahkg @KavinGShah]

@CBS WTF why am in paying for your crap “all-access”?? I can’t even watch the ONE thing that I need…NFL. FIX IT.

[shahkg @KavinGShah]

Amen! https://t.co/k7FSwcyLMX

[shahkg @KavinGShah]

I wonder how Luxterna will do; let’s see if their pricing strategy works. RT @JacobPlieth: So, about those super-expensive drugs: Glybera (total patients treated in commercial setting = 1), Strimvelis (4), Yescarta (5).

[shahkg @KavinGShah]

@Delta Why does your customer service suck so bad?? Waited over 4 hours in total only to be hung up on 2x. Good lord I hope I never have to fly with you again.

[shahkg @KavinGShah]

Exactly! https://t.co/nX3mdBYBfS

[Bishal Gyawali, MD, PhD, FASCO @oncology_bg]

No point in getting excited about biosimilars if they’re going to cost similar to the parent drug. I’d rather use the original molecule if there’s not much price difference! https://t.co/qx4iPXJSDa